| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AXSM over the last quarter tilts toward selling: insiders offloaded a net 118,682 shares worth roughly $26.9M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
Not all activity pointed one way: 1 insider sold in the same window. Classified under Biotechnology (Health Care sector), AXSM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 58.4K | $12.59M | - | |
| Dir | 30.4K | $6.56M | - | |
| COO | 8.7K | $1.87M | - | |
| CFO | 8.2K | $1.77M | - | |
| Other | 7.2K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 7,910 | $74.31 | $587,813.46 | -57.8% | +18.2% | +39.1% | |
| May 29, 2024 | Coleman Mark | Director | Sell | 10,497 | $75.17 | $789,107.29 | -23.4% | +18.2% | +39.1% | |
| Apr 1, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 24,662 | $77.24 | $1,904,942.20 | -100% | +5.2% | +45.0% | |
| Mar 15, 2024 | Jeffs Roger64 | Director | Sale+OE | 32,323 | $69.84 | $2,257,449.25 | -8.2% | -4.0% | +61.4% | |
| Sep 15, 2023 | Coleman Mark | Director | Sale+OE | 29,588 | $75.18 | $2,224,430.37 | -6.5% | -2.6% | +24.5% | |
| Nov 19, 2021 | Jeffs Roger64 | Director | Buy | 3,950 | $37.30 | $147,350.01 | +3.4% | -15.1% | +56.9% | |
| Nov 18, 2021 | Pizzie Nick50 | Chief Financial Officer | Buy | 955 | $35.26 | $33,676.03 | +2.3% | -11.2% | +57.8% | |
| Nov 18, 2021 | Coleman Mark | Director | Buy | 1,430 | $35.09 | $50,180.73 | +0.2% | -11.2% | +57.8% | |
| Nov 17, 2021 | Saad Mark E50 | Director | Buy | 3,300 | $34.52 | $113,921.70 | +47.1% | -2.3% | +54.2% | |
| May 12, 2021 | Coleman Mark | Director | Buy | 500 | $58.15 | $29,075.00 | +0.1% | -58.3% | -55.6% |